-
-
Toggle navigation
Impact Factor 3.113 | CiteScore 3.03
More on impact ›
in Medicine |
|
Submit your manuscript
Scope
Infectious Diseases - Surveillance, Prevention and Treatment is a specialty section of Frontiers in Medicine and Frontiers in Public Health that provides an interactive forum to open new perspectives and publish research advances that unravel the mechanisms and determinants of human infections, including host-pathogen interactions and microbial pathogen adaptation at patient and population levels, and translate this knowledge into innovative diagnostic, therapeutic and preventative interventions.
Scope
Medicine and public health are facing the threats of emerging infectious diseases and antimicrobial drug resistance dissemination in a globalised world. Interdisciplinary research approaches are key to the understanding, assessment and management of these threats.
This section aims at strengthening and appraising the evidence base to inform clinical and public health practice and improve the effectiveness of infectious disease detection, surveillance, management and control. This section will publish research advances that unravel the mechanisms and determinants of human infections, host-pathogen interaction at patient and population levels, risk factors for and clinical presentation of infectious diseases and translate this knowledge into innovative therapeutic and preventative interventions.
Research scope includes:
• detection, investigation, surveillance, management and control of infectious disease, including emerging infections, healthcare-associated infections and infections in compromised hosts
• determination of risk factors and prognostic markers of infectious disease in humans
• molecular and genomic epidemiology investigations of sources and mode of transmission of viral, bacterial, fungal and parasitic infections in humans
• molecular and genomic epidemiology investigations and surveillance of emergence and spread of antimicrobial drug resistance in human pathogens and zoonotic pathogens in a One Health perspective
• control strategies and practice to contain drug resistance and improve patient safety and quality of infectious disease care, including antimicrobial stewardship and infection control
• outbreak investigation and control reports
• case reports and case series of infection caused by new or emerging pathogens or with unusual clinical presentation or treatment outcomes
• clinical development and applications of novel anti-infective therapeutics including antimicrobial agents and alternative therapies with faecal microbiota transplant (FMT), phages and antimicrobial peptides
• clinical trials of anti-infective therapeutics, companion diagnostics or patient care pathways
• public health interventions to prevent infectious diseases, including assessment of vaccine efficacy and immunisation programme effectiveness
The section encourage authors to consult scientific reporting guidelines, such as CONSORT, STROBE, PRISMA, and their specific infectious disease elaborations such as MICRO, STROME-ID, STROBE-AMS, STROBE-NI, and ORION Statement (see equator-network.org).
Indexed in: PubMed, PubMed Central, Scopus, Google Scholar, DOAJ, Emerging Sources Citation Index, CLOCKSS
PMCID: all published articles receive a PMCID
Infectious Diseases – Surveillance, Prevention and Treatment welcomes submissions of the following article types: Brief Research Report, Case Report, Clinical Trial, Correction, Editorial, General Commentary, Hypothesis and Theory, Methods, Mini Review, Opinion, Original Research, Perspective, Review, Specialty Grand Challenge, Study Protocol, Systematic Review and Technology and Code.
All manuscripts must be submitted directly to the section Infectious Diseases – Surveillance, Prevention and Treatment, where they are peer-reviewed by the Associate and Review Editors of the specialty section.
Articles published in the section Infectious Diseases – Surveillance, Prevention and Treatment will benefit from the Frontiers impact and tiering system after online publication. Authors of published original research with the highest impact, as judged democratically by the readers, will be invited by the Chief Editor to write a Frontiers Focused Review - a tier-climbing article. This is referred to as "democratic tiering". The author selection is based on article impact analytics of original research published in all Frontiers specialty journals and sections. Focused Reviews are centered on the original discovery, place it into a broader context, and aim to address the wider community across all of Medicine and Public Health.
Frontiers Editorial Office
Avenue du Tribunal Fédéral 34
CH – 1005 Lausanne
Switzerland
Tel +41(0)21 510 17 40
Fax +41 (0)21 510 17 01
Frontiers Support
Tel +41(0)21 510 17 10
Fax +41 (0)21 510 17 01
support@frontiersin.org
There are no results to display.
Click on any of the keywords to find further editors related to it.
- Article(s) found
- Latest
- Most viewed
This section has no articles.
There are no articles to display. Please try changing the filters.
- Research Topic(s) found
- Latest
- Most viewed
Contact Editorial Office
Avenue du Tribunal Fédéral 34
CH – 1005 Lausanne
Switzerland
Tel +41(0)21 510 17 40
Fax +41 (0)21 510 17 01
For all queries regarding manuscripts in Review and potential conflicts of interest, please contact medicine.editorial.office@frontiersin.org
For queries regarding Research Topics, Editorial Board applications, and journal development, please contact medicine@frontiersin.org
Tel +41(0)21 510 17 10
Fax +41 (0)21 510 17 01
For technical issues, please visit our Frontiers Help Center, or contact our IT HelpDesk team at support@frontiersin.org